Authors:
SOL N
TREBOUTE C
GOMAS E
FERCHAL F
SHACKLETT B
ALIZON M
Citation: N. Sol et al., THE RHESUS MACAQUE CCR3 CHEMOKINE RECEPTOR IS A CELL ENTRY COFACTOR FOR HIV-2, BUT NOT FOR HIV-1, Virology, 240(2), 1998, pp. 213-220
Authors:
LABROSSE B
BRELOT A
HEVEKER N
SOL N
SCHOLS D
DECLERCQ E
ALIZON M
Citation: B. Labrosse et al., DETERMINANTS FOR SENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS CORECEPTOR CXCR4 TO THE BICYCLAM AMD3100, Journal of virology, 72(8), 1998, pp. 6381-6388
Authors:
BRELOT A
HEVEKER N
PLESKOFF O
SOL N
ALIZON M
Citation: A. Brelot et al., ROLE OF THE FIRST AND 3RD EXTRACELLULAR DOMAINS OF CXCR-4 IN HUMAN-IMMUNODEFICIENCY-VIRUS CORECEPTOR ACTIVITY, Journal of virology, 71(6), 1997, pp. 4744-4751
Citation: O. Pleskoff et al., HUMAN-IMMUNODEFICIENCY-VIRUS STRAINS DIFFER IN THEIR ABILITY TO INFECT CD4(-4 (FUSIN)() CELLS EXPRESSING THE RAT HOMOLOG OF CXCR), Journal of virology, 71(4), 1997, pp. 3259-3262
Authors:
LABROSSE B
PLESKOFF O
SOL N
JONES C
HENIN Y
ALIZON M
Citation: B. Labrosse et al., RESISTANCE TO A DRUG BLOCKING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENTRY (RPR103611) IS CONFERRED BY MUTATIONS IN GP41, Journal of virology, 71(11), 1997, pp. 8230-8236
Authors:
SOL N
FERCHAL F
BRAUN J
PLESKOFF O
TREBOUTE C
ANSART I
ALIZON M
Citation: N. Sol et al., USAGE OF THE CORECEPTORS CCR-5, CCR-3, AND CXCR-4 BY PRIMARY AND CELLLINE-ADAPTED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2, Journal of virology, 71(11), 1997, pp. 8237-8244
Authors:
PLESKOFF O
SOL N
MARRAKCHI H
SERLIN M
SEMAN M
ALIZON M
Citation: O. Pleskoff et al., POSSIBLE ROLE OF THE V3 DOMAIN OF GP120 IN RESISTANCE TO AN AMPHOTERICIN-B DERIVATIVE (MS8209) BLOCKING HUMAN-IMMUNODEFICIENCY-VIRUS ENTRY, Journal of virology, 70(11), 1996, pp. 8247-8251
Citation: N. Sol et al., TRANSACTIVATION OF THE LONG TERMINAL REPEAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY THE PARVOVIRUS B19 NS1 GENE-PRODUCT, Journal of General Virology, 74, 1993, pp. 2011-2014